Shares of biopharmaceutical company Soleno Therapeutics, Inc. (SLNO) were in the spotlight on Monday after the company ...

In this article, we are going to take a look at where Soleno Therapeutics Inc. (NASDAQ:SLNO) stands against other firms that end Friday strong. Wall Street’s main indices finished the trading ...

Soleno Therapeutics stock has surged over 1,500% ... ACADIA Pharmaceuticals Inc. (ACAD) has a Phase 3 study of its candidate ACP-101, an intranasal formulation of carbetocin, a long-acting ...

NASDAQ:SLNO opened at $73.67 on Monday. Soleno Therapeutics has a 52-week low of $36.61 and a 52-week high of $73.97. The firm has a market cap of $3.38 billion, a P/E ratio of -22.19 and a beta ...

INDICATION VYKAT XR is indicated for the treatment of hyperphagia in adults and pediatric patients 4 years of age and older with Prader-Willi syndrome (PWS). Contraindications Use of VYKAT XR is ...

Soleno Therapeutics, Inc. has a 1-year low of $36.61 and a 1-year high of $72.96. The company has a market cap of $3.09 billion, a price-to-earnings ratio of -20.30 and a beta of -1.70. Want More ...

We recently published a list of 10 Stocks Jump, Defy Market Uncertainties on Thursday. In this article, we are going to take a look at where Soleno Therapeutics Inc. (NASDAQ:SLNO) stands against other ...

In this article, we are going to take a look at where Soleno Therapeutics Inc. (NASDAQ:SLNO) stands against other stocks that outperformed broader market last week. Wall Street’s main indices ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...